{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:28:50Z","timestamp":1773739730149,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"DOI":"10.7759\/cureus.27837","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T05:44:01Z","timestamp":1660110241000},"source":"Crossref","is-referenced-by-count":4,"title":["Is Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Effective in Ovarian Cancer With Peritoneal Metastasis?"],"prefix":"10.7759","author":[{"given":"Amad","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosab","family":"Hor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed  M","family":"Baradeiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hodan","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Ovarian cancer","author":"Arora T","year":"2022","unstructured":"Arora T, Mullangi S, Lekkala MR. Ovarian cancer. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer CB","year":"2018","unstructured":"Tempfer CB, Giger-Pabst U, Seebacher V, Petersen M, Dogan A, Rezniczek GA. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol. 2018, 150:23-30. 10.1016\/j.ygyno.2018.05.001","journal-title":"Gynecol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/gs-2019-ursoc-12","article-title":"Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review","volume":"10","author":"Oh S","year":"2021","unstructured":"Oh S, Paik H, Park SJ, Lee EJ, Kim HS. Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review. Gland Surg. 2021, 10:1244-51. 10.21037\/gs-2019-ursoc-12","journal-title":"Gland Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami M","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, et al.. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019, 20:e368-77. 10.1016\/S1470-2045(19)30318-3","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-20-497","article-title":"The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review","volume":"12","author":"Lurvink RJ","year":"2021","unstructured":"Lurvink RJ, Van der Speeten K, Rovers KP, de Hingh IH. The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review. J Gastrointest Oncol. 2021, 12:S259-70. 10.21037\/jgo-20-497","journal-title":"J Gastrointest Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010034","article-title":"Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"12","author":"Nadiradze G","year":"2019","unstructured":"Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich FJ, K\u00f6nigsrainer A, Reymond MA. Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers (Basel). 2019, 12:34. 10.3390\/cancers12010034","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.05.007","article-title":"Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study","volume":"45","author":"Sgarbura O","year":"2019","unstructured":"Sgarbura O, H\u00fcbner M, Alyami M, et al.. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: a multicenter study. Eur J Surg Oncol. 2019, 45:2386-91. 10.1016\/j.ejso.2019.05.007","journal-title":"Eur J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-014-0312-y","article-title":"Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review","volume":"164","author":"Tempfer CB","year":"2014","unstructured":"Tempfer CB, Solass W, Reymond MA. Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review. Wien Med Wochenschr. 2014, 164:519-28. 10.1007\/s10354-014-0312-y","journal-title":"Wien Med Wochenschr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis UA","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016, 2:16061. 10.1038\/nrdp.2016.61","journal-title":"Nat Rev Dis Primers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081044","article-title":"Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature","volume":"11","author":"Thomakos N","year":"2019","unstructured":"Thomakos N, Diakosavvas M, Machairiotis N, Fasoulakis Z, Zarogoulidis P, Rodolakis A. Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature. Cancers (Basel). 2019, 11:10.3390\/cancers11081044","journal-title":"Cancers (Basel)"},{"key":"ref11","article-title":"Peritoneal cancer","author":"Anwar A","year":"2022","unstructured":"Anwar A, Kasi A. Peritoneal cancer. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174318","article-title":"Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response","volume":"13","author":"Rickard BP","year":"2021","unstructured":"Rickard BP, Conrad C, Sorrin AJ, et al.. Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response. Cancers (Basel). 2021, 13:10.3390\/cancers13174318","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2018.09.007","article-title":"Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature","volume":"92","author":"Kastelein AW","year":"2019","unstructured":"Kastelein AW, Vos LM, de Jong KH, et al.. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Semin Cell Dev Biol. 2019, 92:27-36. 10.1016\/j.semcdb.2018.09.007","journal-title":"Semin Cell Dev Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1369\/0022155417742897","article-title":"Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review","volume":"66","author":"van Baal JO","year":"2018","unstructured":"van Baal JO, van Noorden CJ, Nieuwland R, et al.. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. J Histochem Cytochem. 2018, 66:67-83. 10.1369\/0022155417742897","journal-title":"J Histochem Cytochem"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \"soil\" for a cancerous \"seed\": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Miku\u0142a-Pietrasik J","year":"2018","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Tykarski A, Ksi\u0105\u017cek K. The peritoneal \"soil\" for a cancerous \"seed\": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci. 2018, 75:509-25. 10.1007\/s00018-017-2663-1","journal-title":"Cell Mol Life Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3039-x","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects","volume":"20","author":"Solass W","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013, 20:3504-11. 10.1245\/s10434-013-3039-x","journal-title":"Ann Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Sola\u00df W","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012, 26:1849-55. 10.1007\/s00464-012-2148-0","journal-title":"Surg Endosc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer CB","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W, et al.. Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol. 2014, 132:307-11. 10.1016\/j.ygyno.2013.11.022","journal-title":"Gynecol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"20","author":"Blanco A","year":"2013","unstructured":"Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2013, 20:2311-6. 10.1245\/s10434-012-2840-2","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini F","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, et al.. Peritoneal carcinomatosis. World J Gastroenterol. 2013, 19:6979-94. 10.3748\/wjg.v19.i41.6979","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"14","author":"Robella M","year":"2016","unstructured":"Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol. 2016, 14:128. 10.1186\/s12957-016-0892-7","journal-title":"World J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i35.12493","article-title":"Current treatment options for colon cancer peritoneal carcinomatosis","volume":"20","author":"Aoyagi T","year":"2014","unstructured":"Aoyagi T, Terracina KP, Raza A, Takabe K. Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol. 2014, 20:12493-500. 10.3748\/wjg.v20.i35.12493","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-18890-0_23","article-title":"Management of peritoneal malignancies","author":"Berri RN","year":"2019","unstructured":"Berri RN, Ford JM. Management of peritoneal malignancies. Textbook of gastrointestinal oncology. Yalcin S, Philip P (ed): Springer, Cham, Switzerland; 2019. 395-420. 10.1007\/978-3-030-18890-0_23"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"41","author":"Odendahl K","year":"2015","unstructured":"Odendahl K, Solass W, Demtr\u00f6der C, Giger-Pabst U, Zieren J, Tempfer C, Reymond MA. Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Eur J Surg Oncol. 2015, 41:1379-85. 10.1016\/j.ejso.2015.06.001","journal-title":"Eur J Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally R","year":"2016","unstructured":"Girshally R, Demtr\u00f6der C, Albayrak N, Zieren J, Tempfer C, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2016, 14:253. 10.1186\/s12957-016-1008-0","journal-title":"World J Surg Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2743985","article-title":"Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study","volume":"2018","author":"Kurtz F","year":"2018","unstructured":"Kurtz F, Struller F, Horvath P, Solass W, B\u00f6sm\u00fcller H, K\u00f6nigsrainer A, Reymond MA. Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study. Gastroenterol Res Pract. 2018, 2018:2743985. 10.1155\/2018\/2743985","journal-title":"Gastroenterol Res Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2021-0108","article-title":"The ISSPP PIPAC database: design, process, access, and first interim analysis","volume":"6","author":"Mortensen MB","year":"2021","unstructured":"Mortensen MB, Glehen O, Horvath P, et al.. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum. 2021, 6:91-7. 10.1515\/pp-2021-0108","journal-title":"Pleura Peritoneum"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918777036","article-title":"Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis","volume":"10","author":"Graversen M","year":"2018","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, Fristrup CW, Pfeiffer P, Mortensen MB. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis. Ther Adv Med Oncol. 2018, 10:1758835918777036. 10.1177\/1758835918777036","journal-title":"Ther Adv Med Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105406-is-pressurized-intraperitoneal-aerosolized-chemotherapy-pipac-effective-in-ovarian-cancer-with-peritoneal-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:35Z","timestamp":1707507455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105406-is-pressurized-intraperitoneal-aerosolized-chemotherapy-pipac-effective-in-ovarian-cancer-with-peritoneal-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.27837","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}